FDA Approves Koselugo for Pediatric Neurofibromatosis Type 1
Apr16
Title: FDA Approves Koselugo for Pediatric Neurofibromatosis Type 1
Category: Health News
Created: 4/14/2020 12:00:00 AM
Last Editorial Review: 4/15/2020 12:00:00 AM
Title: FDA Approves Koselugo for Pediatric Neurofibromatosis Type 1
Category: Health News
Created: 4/14/2020 12:00:00 AM
Last Editorial Review: 4/15/2020 12:00:00 AM
Discussion ¬